Our laboratory is focused on identifying therapeutic targets for kidney diseases. Acute kidney injury and renal cell carcinoma are the two major areas of interest. Our recent work has identified several protein kinases and membrane transporters as therapeutic targets for renal disorders. We utilize high throughput screening assays and functional genomics to identify molecular targets for renal diseases, followed by validation in in vivo animal models. The overall goal of these studies is to identify new therapeutic strategies to treat acute kidney injury and renal cell carcinoma, diseases for which no effective therapies are currently available.
Yuntao Bai, PhD, Post-Doctoral Researcher
Ji Young Kim, PhD, Post-Doctoral Researcher
Postdoctoral fellow, 2015, Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN.
PhD, 2009, Biomedical Sciences, Medical College of Georgia, Augusta, GA.
MSc, 2003, Biochemistry, M.S. University of Baroda, Gujarat, India.
BSc, 2001, Biotechnology, S.P. University, Gujarat, India
- Cancer Res.. 2016 Nov 15;24(22):5855-5860.
- Nat Commun. 2016;7:10880
- Arch Toxicol. 2015 Dec;89(12):2197-205.
- Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5231-6